Guangdong Tai'an Tang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
Special Reminder:
- The Company's stock will be delisted on the trading day following the end of the delisting transition period.
- The start date of the delisting transition period for the Company's stock is June 14, 2024, lasting for fifteen trading days, with the expected last trading date being July 4, 2024.
- The Company's stock will trade for fifteen trading days during the delisting transition period. The date of this announcement (July 3, 2024) is the 14th trading day, leaving 1 trading day remaining. The stock will be delisted after the trading period ends; investors are advised to invest cautiously and pay attention to risks.
- During the delisting transition period, the Company will not plan or implement any major asset restructuring matters.
- Investors, securities companies, and other market participants should settle stock pledge repurchase, agreed repurchase, margin financing, transfer, and Shenzhen Stock Connect businesses in a timely manner before the stock is delisted.
- For judicial freeze businesses that will expire after the stock is delisted and before the completion of the initial registration in the delisting sector, it is recommended that the competent authorities handle the renewal procedures in advance through the original enforcement channels before the stock is delisted.